Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.

Puertas MC, Noguera-Julian M, Massanella M, Pou C, Buzon MJ, Clotet B, Stevenson M, Paredes R, Blanco J, Martinez-Picado J.

Retrovirology. 2016 Aug 2;13(1):51. doi: 10.1186/s12977-016-0282-9.

2.

ART-suppressed subjects with low CD4 T-cell counts segregate according to opposite immunological phenotypes.

Pérez-Santiago J, Ouchi D, Urrea V, Carrillo J, Cabrera C, Villà-Freixa J, Puig J, Paredes R, Negredo E, Clotet B, Massanella M, Blanco J.

AIDS. 2016 Jul 16. [Epub ahead of print]

PMID:
27427875
3.

Gut Microbiota Linked to Sexual Preference and HIV Infection.

Noguera-Julian M, Rocafort M, Guillén Y, Rivera J, Casadellà M, Nowak P, Hildebrand F, Zeller G, Parera M, Bellido R, Rodríguez C, Carrillo J, Mothe B, Coll J, Bravo I, Estany C, Herrero C, Saz J, Sirera G, Torrela A, Navarro J, Crespo M, Brander C, Negredo E, Blanco J, Guarner F, Calle ML, Bork P, Sönnerborg A, Clotet B, Paredes R.

EBioMedicine. 2016 Jan 28;5:135-46. doi: 10.1016/j.ebiom.2016.01.032. eCollection 2016 Mar.

4.

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

Jarrin I, Pantazis N, Dalmau J, Phillips AN, Olson A, Mussini C, Boufassa F, Costagliola D, Porter K, Blanco J, Del Amo J, Martinez-Picado J; for CASCADE Collaboration in EuroCoord.

AIDS. 2015 Nov;29(17):2323-33. doi: 10.1097/QAD.0000000000000805.

PMID:
26544704
5.

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy.

Morón-López S, Gómez-Mora E, Salgado M, Ouchi D, Puertas MC, Urrea V, Navarro J, Jou A, Pérez M, Tural C, Clotet B, Montaner LJ, Blanco J, Crespo M, Martinez-Picado J.

J Infect Dis. 2016 Mar 15;213(6):1008-12. doi: 10.1093/infdis/jiv521. Epub 2015 Nov 1.

PMID:
26525407
6.

Increased ex vivo cell death of central memory CD4 T cells in treated HIV infected individuals with unsatisfactory immune recovery.

Massanella M, Gómez-Mora E, Carrillo J, Curriu M, Ouchi D, Puig J, Negredo E, Cabrera C, Clotet B, Blanco J.

J Transl Med. 2015 Jul 17;13:230. doi: 10.1186/s12967-015-0601-2.

7.

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.

Lazaro I, Oguiza A, Recio C, Mallavia B, Madrigal-Matute J, Blanco J, Egido J, Martin-Ventura JL, Gomez-Guerrero C.

Diabetes. 2015 Oct;64(10):3600-13. doi: 10.2337/db14-1926. Epub 2015 Jun 26.

8.

Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina.

Giorgi MA, Caroli C, Giglio ND, Micone P, Aiello E, Vulcano C, Blanco J, Donato B, Quevedo JM.

Health Econ Rev. 2015 Dec;5(1):52. doi: 10.1186/s13561-015-0052-8. Epub 2015 Jun 26.

9.

Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.

Oguiza A, Recio C, Lazaro I, Mallavia B, Blanco J, Egido J, Gomez-Guerrero C.

Diabetologia. 2015 Jul;58(7):1656-67. doi: 10.1007/s00125-015-3596-6. Epub 2015 Apr 28.

PMID:
25982245
10.

Gp120/CD4 blocking antibodies are frequently elicited in ART-naïve chronically HIV-1 infected individuals.

Carrillo J, Molinos-Albert LM, Rodríguez de la Concepción ML, Marfil S, García E, Derking R, Sanders RW, Clotet B, Blanco J.

PLoS One. 2015 Mar 24;10(3):e0120648. doi: 10.1371/journal.pone.0120648. eCollection 2015.

11.

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

Mothe B, Climent N, Plana M, Rosàs M, Jiménez JL, Muñoz-Fernández MÁ, Puertas MC, Carrillo J, Gonzalez N, León A, Pich J, Arnaiz JA, Gatell JM, Clotet B, Blanco J, Alcamí J, Martinez-Picado J, Alvarez-Fernández C, Sánchez-Palomino S, Guardo AC, Peña J, Benito JM, Rallón N, Gómez CE, Perdiguero B, García-Arriaza J, Esteban M, López Bernaldo de Quirós JC, Brander C, García F; RISVAC-03 Study Group.

J Antimicrob Chemother. 2015;70(6):1833-42. doi: 10.1093/jac/dkv046. Epub 2015 Feb 26.

12.

Rapid HIV progression during acute HIV-1 subtype C infection in a Mozambican patient with atypical seroconversion.

Velasco C, Parker E, Pastor L, Nhama A, Macuacua S, Mandomando I, Blanco J, Naniche D.

Am J Trop Med Hyg. 2015 Apr;92(4):681-3. doi: 10.4269/ajtmh.14-0554. Epub 2015 Jan 26.

13.

Glomerulonephritis and cryoglobulinemia: first manifestation of visceral leishmaniasis.

Ortiz M, Mon C, Herrero JC, Oliet A, Rodríguez I, Ortega O, Gallar P, Hinostroza J, Cobo G, del Alamo M, Jiménez J, Torres R, Digiogia C, San Martin J, Vigil AI, Blanco J.

Clin Nephrol. 2015 Jun;83(6):370-7. doi: 10.5414/CN108195.

PMID:
25600859
14.

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals.

Massanella M, Ouchi D, Marfil S, Llibre JM, Puertas MC, Buzón MJ, Richman DD, Orna E, Stevenson M, Gatell JM, Domingo P, Negredo E, Martinez-Picado J, Clotet B, Blanco J.

PLoS One. 2014 Dec 2;9(12):e114142. doi: 10.1371/journal.pone.0114142. eCollection 2014.

15.

Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individuals.

Molinos-Albert LM, Carrillo J, Curriu M, Rodriguez de la Concepción ML, Marfil S, García E, Clotet B, Blanco J.

Retrovirology. 2014 Jun 7;11:44. doi: 10.1186/1742-4690-11-44.

16.

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.

Kawana-Tachikawa A, Llibre JM, Bravo I, Escrig R, Mothe B, Puig J, Puertas MC, Martinez-Picado J, Blanco J, Manzardo C, Miro JM, Iwamoto A, Pozniak AL, Gatell JM, Clotet B, Brander C; MARAVIBOOST Investigators.

PLoS One. 2014 Jan 27;9(1):e87334. doi: 10.1371/journal.pone.0087334. eCollection 2014.

17.

Hyperlipidemia-associated renal damage decreases Klotho expression in kidneys from ApoE knockout mice.

Sastre C, Rubio-Navarro A, Buendía I, Gómez-Guerrero C, Blanco J, Mas S, Egido J, Blanco-Colio LM, Ortiz A, Moreno JA.

PLoS One. 2013 Dec 30;8(12):e83713. doi: 10.1371/journal.pone.0083713. eCollection 2013.

18.

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection.

Puertas MC, Massanella M, Llibre JM, Ballestero M, Buzon MJ, Ouchi D, Esteve A, Boix J, Manzardo C, Miró JM, Gatell JM, Clotet B, Blanco J, Martinez-Picado J; MaraviBoost Collaborative Group.

AIDS. 2014 Jan 28;28(3):325-34. doi: 10.1097/QAD.0000000000000066.

PMID:
24185044
19.

Immunodiscordant responses to HAART--mechanisms and consequences.

Massanella M, Negredo E, Clotet B, Blanco J.

Expert Rev Clin Immunol. 2013 Nov;9(11):1135-49. doi: 10.1586/1744666X.2013.842897. Review.

PMID:
24168417
20.

The effect of cell subset isolation method on gene expression in leukocytes.

Beliakova-Bethell N, Massanella M, White C, Lada SM, Du P, Vaida F, Blanco J, Spina CA, Woelk CH.

Cytometry A. 2014 Jan;85(1):94-104. doi: 10.1002/cyto.a.22352. Epub 2013 Sep 20.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk